Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Bio-Techne Corp at Leerink Partners Global Healthcare Conference Transcript

Feb 27, 2019 / 03:30PM GMT
Release Date Price: €41.44 (-2.22%)
Puneet Souda
SVB Leerink LLC, Research Division - MD of Life Science Tools, Diagnostics, and Senior Research Analyst

So glad to have everyone here. Let's get started. So it's my pleasure to host Bio-Techne's CEO, Chuck Kummeth; and CFO, Jim Hippel. Great to have you guys here.

I'm Puneet Souda, SVB Leerink Tools and Diagnostic Analyst. So maybe first -- we have a different format this year. So let's get -- jump into couple of slides, and then we can jump to questions after that.

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Okay. Looks like it's on. I'll rip through these quick, a little bit -- it's a primer on our company.

So we're roughly $7 billion or so market cap. We've grown from 700 people to 2,100 in the last 5, 6 years.

You can see our fiscal 2008 revenues there. You can see our breakup. This 65% is kind of the original portions of the company. It's a 42-year-old company, but most of me and my team have been around 5, 6 years, so we're more like a 5-year-old company really.

And we've

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot